1. Home
  2. CSTE vs NRXS Comparison

CSTE vs NRXS Comparison

Compare CSTE & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$2.21

Market Cap

66.7M

Sector

Industrials

ML Signal

HOLD

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$7.06

Market Cap

78.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
NRXS
Founded
1987
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
66.7M
78.9M
IPO Year
2012
2023

Fundamental Metrics

Financial Performance
Metric
CSTE
NRXS
Price
$2.21
$7.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
127.6K
97.4K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.13
EPS
N/A
N/A
Revenue
N/A
$3,569,282.00
Revenue This Year
$3.43
$172.91
Revenue Next Year
$2.83
$115.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.89
52 Week Low
$0.56
$2.20
52 Week High
$2.58
$9.33

Technical Indicators

Market Signals
Indicator
CSTE
NRXS
Relative Strength Index (RSI) 66.90 48.62
Support Level $2.12 $6.79
Resistance Level $2.33 $7.79
Average True Range (ATR) 0.20 0.36
MACD 0.03 0.05
Stochastic Oscillator 49.46 62.50

Price Performance

Historical Comparison
CSTE
NRXS

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa), of which it derives maximum revenue from United States.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: